UK markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6900+0.0400 (+2.42%)
At close: 04:00PM EDT
1.7000 +0.01 (+0.59%)
After hours: 06:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-19,697
-22,555
-21,198
-18,457
-8,445
Depreciation & amortisation
25
31
32
43
20
Stock-based compensation
1,275
1,473
1,506
1,157
430
Change in working capital
8,653
4,939
-1,167
-1,283
61
Accounts payable
756
296
2,577
3,025
30
Other working capital
-9,734
-16,118
-20,834
-18,567
-8,030
Net cash provided by operating activities
-9,734
-16,112
-20,827
-18,540
-7,934
Cash flows from investing activities
Investments in property, plant and equipment
-
-6
-7
-27
-96
Net cash used for investing activities
0
-6
-7
-27
-96
Cash flows from financing activities
Common stock issued
-
1,049
3,199
17,371
25,160
Dividends paid
-151
-201
-201
-201
-201
Net cash used provided by (used for) financing activities
819
848
2,998
21,737
29,504
Net change in cash
-8,637
-14,967
-18,214
3,153
21,521
Cash at beginning of period
11,435
18,345
36,559
33,406
11,885
Cash at end of period
2,520
3,378
18,345
36,559
33,406
Free cash flow
Operating cash flow
-9,734
-16,112
-20,827
-18,540
-7,934
Capital expenditure
-
-6
-7
-27
-96
Free cash flow
-9,734
-16,118
-20,834
-18,567
-8,030